FAULTLINEGlobal event monitor The world todayAll situations

Science & space · Science · Impact 1 Watch

Personalised mRNA vaccine cuts melanoma recurrence or death risk in phase III trial

· ≈ London, United Kingdom · single source so far

Trial results show the custom-made vaccine intismeran significantly reduces the risk of cancer recurrence or death within two years. It is the first individualised cancer vaccine to show positive phase III results.

Location
≈ London, United Kingdom · United Kingdom live map
Coordinates
≈ 51.51°N 0.13°W
Reported
23 Oct 2026, 04:27 UTC
Category
Science & space · Science
Impact
1 of 5 · Watch
Situation
Medical research